Results 201 to 210 of about 506,874 (259)

Exploration and practice: New integration of cellular therapy and hematopoietic stem cell transplantation. [PDF]

Chin Med J (Engl)
Huang R, Zhang X.
europepmc   +1 more source

BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING

Advanced Science, EarlyView.
Based on IP‐MS analysis, BAG2 is confirmed to be essential for ubiquitination and protein homeostasis regulation of STING in cervical cancer. BAG2 inhibits the ubiquitination and degradation of STING by forming a complex with STUB1, thereby activating the type I IFN signaling pathway and inhibiting the development of cervical cancer.
Shijie Yao, Siming Chen, Anjin Wang, Ziyan Liang, Xuelian Liu, Yang Gao, Hongbing Cai   +6 more
wiley   +1 more source

Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential. [PDF]

Exp Hematol Oncol
Tong J, Tan Y, Ouyang W, Chang H.
europepmc   +1 more source

Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy. [PDF]

J Immunother Cancer
Poppe LK, Roller N, Medina-Enriquez MM, Lassoued W, Burnett D, Lothstein KE, Khelifa AS, Miyamoto M, Gulley JL, Jochems C, Schlom J, Gameiro SR.   +11 more
europepmc   +1 more source

Application of nanomedicines in tumor immunotherapy. [PDF]

J Mol Cell Biol
Gao Z, Wan D, Luo M, Wei X.
europepmc   +1 more source

Antitumor/anti-inflammatory effects/tissue healing as an all-in-one therapeutic strategy for nasopharyngeal carcinoma. [PDF]

J Nanobiotechnology
Ni F, Lv H, Lin L, Zhang Y, Qiao Y, Zhang X, Li Z, Wang X, Dai X, Dong J.   +9 more
europepmc   +1 more source

Correction: Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers [PDF]

J Immunother Cancer
europepmc   +1 more source